Clinic
Christus Health Southeast Texas
Christus Health Southeast Texas was paid $5.51M by Medicaid between Jan 2020 and Nov 2024, across 62 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoCHRISTUS HEALTH SOUTHEAST TEXAS
JASPER, TX 75951
JASPER, TX 75951
33aNPI1598749707assigned 12/01/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$5.51M
24GClaims69,994
24DCodes billed62
24AFirst – last monthJan 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#72 of 320
Median peer was paid$205K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TREVINO, PAUL controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,627 | $150K | |
| 2021 | 16,103 | $887K | |
| 2022 | 21,025 | $1.24M | |
| 2023 | 20,922 | $2.04M | |
| 2024incomplete | 10,317 | $1.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 11,070 | 10,568 | $2.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 4,226 | 3,933 | $2.12M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.2% | 1,021 | 921 | $509K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 941 | 914 | $121K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 1,706 | 1,563 | $108K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 3,937 | 1,908 | $83K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,215 | 1,049 | $74K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,439 | 1,393 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,733 | 4,879 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 4,624 | 4,048 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 931 | 885 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 403 | 379 | $20K |
50 more codes
| 87081 | <1% | 1,324 | $19K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 906 | $18K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 54 | $16K |
| 81003 | <1% | 4,101 | $15K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 897 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,512 | $9K |
| 83880 | <1% | 670 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 159 | $7K |
| 84484 | <1% | 1,355 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 854 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 53 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 76 | $4K |
| 87420 | <1% | 162 | $4K | |
| 81025 | <1% | 257 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 44 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 496 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 968 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 605 | $2K |
| 83690 | <1% | 404 | $2K | |
| 87077 | <1% | 700 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 111 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 698 | $1K |
| 87186 | <1% | 510 | $1K | |
| 80061 | Lipid panel | <1% | 728 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 674 | $729.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 177 | $635.07 |
| 80047 | <1% | 58 | $564.42 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 118 | $491.57 |
| 85610 | <1% | 526 | $436.76 | |
| 85730 | <1% | 158 | $371.01 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,295 | $359.63 |
| 83735 | <1% | 267 | $357.39 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $282.60 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 41 | $264.09 |
| 83605 | <1% | 51 | $197.27 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 87 | $195.23 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 40 | $187.41 |
| 87040 | <1% | 26 | $124.81 | |
| 85027 | <1% | 232 | $121.49 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 148 | $82.26 |
| 81001 | <1% | 52 | $71.41 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $61.82 |
| 80164 | <1% | 15 | $17.67 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 263 | $2.85 |
| A9270 | Non-covered item or service | 0% | 670 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 1,999 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 122 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
| 84550 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTREVINO, PAUL (PRESIDENT / CEO)
| Provider | Location | Paid |
|---|---|---|
| Christus Health Southeast Texas | Beaumont, TX | $21.00M |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $11.89M |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $10.18M |
| Christus Health Southeast Texas | Jasper, TX | $699K |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $223K |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $145K |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $136K |
| Christus Health Southwestern Louisiana | Grand Chenier, LA | $113K |
| Christus Health Southeast Texas | Kirbyville, TX | $86K |
| Christus Health Southwestern Louisiana | Lake Charles, LA | $41K |
| Christus Health Southeast Texas | Beaumont, TX | $175.14 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.